This solution will complement Acumed’s hand and wrist portfolio, which includes numerous wrist plating options and the Acutrak 2 Headless Compression Screw. In particular, it will expand the solutions to surgeons treating distal radius fractures that present with concomitant injury to the scapholunate ligament.
“This acquisition will further strengthen Acumed’s position to deliver compelling and comprehensive solutions to address fractures and associated soft tissue injuries of the hand and wrist,” said Acumed President and CEO Sharon Wolfington.
“Acumed will continue to build its portfolio to meet the unmet needs of the fellowship-trained hand and upper extremity, sports medicine, foot and ankle, and trauma surgeons. We will do this both with organic innovation and with acceleration acquisitions,” stated Jagi Gill, vice president and general manager of AcuVentures, a subsidiary of Acumed.
Chronic injury to the scapholunate ligament affects approximately 120,000 persons in the United States every year. “Scapholunate dissociation is one of the most common types of instability of the wrist. Injury to the associated ligament prevents normal motion and contributes to significant pain. One of the features of the RASL System is to provide precise targeting with the intent to afford a straightforward and reproducible solution to this clinical problem. We are excited to see Acumed deliver to the surgical community this new solution to address a vexing condition,” stated Dr. Rosenwasser.
Acumed develops orthopedic and medical solutions to improve patient care. Acumed has three decades of experience in the orthopedic industry, with the mission of aiding the afflicted through the ingenuity of the mind, the labor of the hands, and the compassion of the heart. Founded in 1988, Acumed is headquartered in Hillsboro, Ore., with offices and a distribution network around the world.